Cargando…
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
Osteosarcoma (OS) is the most common form of primary bone tumor affecting mainly children and young adults. Despite therapeutic progress, the 5-year survival rate is 70%, but it drops drastically to 30% for poor responders to therapies or for patients with metastases. Identifying new therapeutic tar...
Autores principales: | Lallier, Morgane, Marchandet, Louise, Moukengue, Brice, Charrier, Celine, Baud’huin, Marc, Verrecchia, Franck, Ory, Benjamin, Lamoureux, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067202/ https://www.ncbi.nlm.nih.gov/pubmed/33808130 http://dx.doi.org/10.3390/cells10040754 |
Ejemplares similares
-
Origin and Therapies of Osteosarcoma
por: Moukengue, Brice, et al.
Publicado: (2022) -
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
por: Marchandet, Louise, et al.
Publicado: (2021) -
Ribosomopathies: New Therapeutic Perspectives
por: Orgebin, Emilien, et al.
Publicado: (2020) -
TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020) -
Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells
por: Tesfaye, Robel A., et al.
Publicado: (2023)